Regulation of iNOS by the p44/42 mitogen-activated protein kinase pathway in human melanoma

Oncogene

Volumn 25, Issue 28, 2006, Pages 3956-3962

  Ellerhorst, J A ^a,b   Ekmekcioglu, S ^a   Johnson, M K ^a   Cooke, C P ^a   Johnson, M M ^a   Grimm, E A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

B Raf; ERK; iNOS; Melanoma; N Ras

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; B RAF KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE;

ARTICLE; BRAF GENE; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INOS GENE; MELANOMA; NRAS GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS;

BASE SEQUENCE; BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; RNA INTERFERENCE;

EID: 33745601390     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209419     Document Type: Article

References (31)

1. Bhat NR, Fan F. (2002). Brain Res 948: 93-101.
2. Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R et al. (2002). Cancer Res 62: 6997-7000.
3. Colasanti M, Suzuki H. (2000). Trends Pharmacol Sci 21: 249-252.
4. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002). Nature 417, 949-954.
5. Demunter A, Stas M, Degreef H, De Wolf-Peters C, van den Oor JJ. (2001). J Invest Dermatol 117: 1483-1489.
6. Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munsell M, Buzaid AC et al. (2000). Clin Cancer Res 6: 4768-4775.
7. Ekmekcioglu S, Ellerhorst JA, Mumm JB, Zheng M, Broemeling L, Prieto VG et al. (2003). Mol Cancer Ther 2: 9-17.
8. Gay RD, Dawson SJ, Murphy WJ, Russell SW, Latchman DS. (1998). Biochim Biophys Acta 1443: 315-322.
9. Goodall J, Wellbrock C, Dexter TJ, Roberts K, Marais R, Gooding CR. (2004). Mol Cell Biol 24: 2923-2931.
10. Gorden A, Osman I, Gai W, He D, Huang W, Davidson A et al. (2003). Cancer Res 63: 3955-3957.
11. Guan KL, Figueroa C, Brtva TR, Zhu T, Taylor J, Barber TD et al. (2000). J Biol Chem 275: 27354-27359.
12. Jaramillo M, Gowda DC, Radzioch D, Olivier M. (2003). J Immunol 171: 4243-4253.
13. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA et al. (1995). Proc Natl Acad Sci USA 92: 4392-4396.
14. Jiang B, Xu S, Hou X, Pimentel DR, Brecher P, Cohen RA. (2004). J Biol Chem 279: 1323-1329.
15. Kleinert H, Schwarz PM, Forstermann U. (2003). Biol Chem 384: 1343-1364.
16. Kristof AS, Marks-Konczalik J, Moss J. (2001). J Biol Chem 276: 8445-8452.
17. Liu X, Jana M, Dasgupta S, Koka S, He J, Wood C et al. (2002). J Biol Chem 277: 39312-39319.
18. Mason CS, Springer CJ, Cooper RG, Superti-Furga G, Marshall CJ, Marais R. (1999). EMBO J 18: 2137-2148.
19. Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L et al. (2001). J Pathol 194: 194-200.
20. Mercer KE, Pritchard CA. (2003). Biochim Biophys Acta 1653: 25-40.
21. Omholt K, Karsberg S, Platz A, Kanter L, Ringborg U, Hansson J. (2002). Clin Cancer Res 8: 3468-3474.
22. Park SK, Lin HL, Murphy S. (1997). Biochem J 322: 609-613.
23. Perrotta C, Falcone S, Capobionca A, Camporeale A, Sciorati C, De Palma C et al. (2004). Cancer Res 64: 3767-3771.
24. Salvucci O, Carsana M, Bersani I, Tragni G, Anichini A. (2001). Cancer Res 61: 318-326.
25. Smalley KSM. (2003). Int J Cancer 104: 527-532.
26. Szabo C, Southan GJ, Thiemermann C. (1994). Proc Natl Acad Sci USA 91: 12472-12476.
27. Tang CH, Grimm EA. (2004). J Biol Chem 279: 288-298.
28. Wink DA, Mitchell JB. (1998). Free Radic Biol Med 25: 434-456.
29. Wink DA, Mitchell JB. (2003). Free Radic Biol Med 34: 951-954.
30. Yazdi AS. (2003). J Invest Dermatol 121: 1160-1162.
31. Zheng M, Ekmekcioglu S, Walch ET, Tang CH, Grimm EA. (2004). Melanoma Res 14: 165-171.